24,25-epoxycholesterol has been researched along with hyperforin in 1 studies
| Studies (24,25-epoxycholesterol) | Trials (24,25-epoxycholesterol) | Recent Studies (post-2010) (24,25-epoxycholesterol) | Studies (hyperforin) | Trials (hyperforin) | Recent Studies (post-2010) (hyperforin) |
|---|---|---|---|---|---|
| 65 | 0 | 18 | 397 | 20 | 144 |
| Protein | Taxonomy | 24,25-epoxycholesterol (IC50) | hyperforin (IC50) |
|---|---|---|---|
| Prostaglandin E synthase | Homo sapiens (human) | 1 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 2.3 | |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 2 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 2 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Castell, JV; Gómez-Lechón, MJ; Jover, R; Moya, M | 1 |
1 other study(ies) available for 24,25-epoxycholesterol and hyperforin
| Article | Year |
|---|---|
Enhanced steatosis by nuclear receptor ligands: a study in cultured human hepatocytes and hepatoma cells with a characterized nuclear receptor expression profile.
Topics: Androstenols; Bridged Bicyclo Compounds; Calcifediol; Cells, Cultured; Cholesterol; Farnesol; Fatty Liver; Hep G2 Cells; Hepatocytes; Humans; Indoles; Ligands; Phloroglucinol; PPAR gamma; Pregnenediones; Receptors, Cytoplasmic and Nuclear; Selective Estrogen Receptor Modulators; Tamoxifen; Terpenes; Vitamin A | 2010 |